Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07492134
Eligibility Criteria:
Inclusion Criteria:
* Patients presenting to the emergency department with left-sided uncomplicated diverticulitis
* Radiologic score (moderate diverticulitis per Ambrosetti classification)
* Age 18-90
* Access to a smartphone with internet access.
Exclusion Criteria:
* Complicated diverticulitis (abscess, free air, peritonitis)- severe diverticulitis by Ambrosetti classification
* Diverticulitis other than left colon
* Contraindication to use of study medication (ie advanced renal failure or allergy to all antibiotics used in the study)
* Concurrent cancer diagnosis
* Concurrent IBD Diagnosis
* Any other disease process with life expectancy \< 6 months
* Concurrent chronic pain diagnosis.
* Women in pregnancy or breastfeeding
* Antibiotic treatment for any reason in the last 3 weeks
* Diagnosis of prior episode of acute diverticulitis in the past 3 months
* Significant comorbidities: diabetes mellitus with organic involvement (retinopathy, angiopathy, nephropathy), emergency assistance for a cardiogenic event in the last 3 months (acute myocardial infarction, angina, heart failure), decompensation of chronic liver disease in the last 3 months (Child ≥ B) and end-stage renal disease.
* Immunodepression: the absence, and immunodepression is the presence, of any of the following: active neoplastic disease, hematologic malignancy, human immunodeficiency virus long-term corticosteroid treatment, immunosuppressant therapy (20mg pred (or equivalent) for \>2 weeks), transplant, splenectomy and genetic immunodeficiency
* Previous colectomy
* Patients with dementia, memory disorders or other cognitive impairment that would impact their ability to provide informed consent or otherwise participate in the trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT07492134
Study Brief:
Protocol Section:
NCT07492134